Antidepressant Market Will Be Flat In 2005, Forest And Wyeth Predict
Executive Summary
The U.S. antidepressant market will likely be flat in 2005, marketers of selective serotonin reuptake inhibitors and serotonin/norepinephrine reuptake inhibitors predict
You may also be interested in...
Impact of Antidepressant Black Box Juggled By Advisory Committee, FDA
The addition of new, positive data on adult suicidality to antidepressant labeling could be an opportunity to offset the negative impact the "black box" warning on pediatric suicidality has had on antidepressant use, according to members of FDA's Psychopharmacologic Drugs Advisory Committee
Impact of Antidepressant Black Box Juggled By Advisory Committee, FDA
The addition of new, positive data on adult suicidality to antidepressant labeling could be an opportunity to offset the negative impact the "black box" warning on pediatric suicidality has had on antidepressant use, according to members of FDA's Psychopharmacologic Drugs Advisory Committee
Branded Antidepressants Face Challenges With Part D Formulary Positions
The Centers for Medicare & Medicaid Services appears to be interpreting its "all or substantially all" policy for Part D plan coverage of antidepressants as allowing sponsors to include the majority of agents on high cost-sharing tiers, according to analysis of plan formularies conducted by "The Pink Sheet."